Page 7 - Pharma Stocks

Laurus Labs falls 6% despite strong Q4 results: Here's what brokerages say

Laurus Labs stock was quoting at ₹618.50, down 4.18 per cent from the previous session's closing price of ₹645.50

This smallcap pharma stock surges 10%, nears record high. Do you own?

Vimta Labs shares soared 10% to ₹1,148.15 on the BSE in intra-day trade after the company said its board will meet on Monday, April 28, 2025, to consider a proposal for the issue of bonus shares.

Trend turns favourable for GlaxoSmithKline Pharma, key levels to track

GlaxoSmithKline Pharma stock has seen formation of 'Golden Cross' on the daily chart on Thursday; last time the stock saw a similar development, it rallied almost 117% over the next 14 months.

Sensex rejoices on Trump tariff halt, jumps 1,300 pts; Metals, pharma lead

However, on a weekly basis, the Sensex and Nifty posted a decline of 0.27 per cent and 0.33 per cent, respectively

Biocon subsidiary gets USFDA nod for Everolimus tablets; share zooms 6%

The rise in the Biocon share price came after its wholly-owned unit, Biocon Pharma, received USFDA nod for Everolimus tablets.

Aurobindo Pharma shares jump 4% as arm completes phase1 trial for bone drug

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the cells that break down bone

Cipla share price jumps 5% as USFDA okays cancer drug Paclitaxel

Cipla said USFDA has approved the ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-Dose Vial ('Protein-bound Paclitaxel') on Apr 10

Here's why Sun Pharma share price advanced 5% in trade on April 11; details

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of Leqselvi (deuruxolitinib).

Pharma shares slide up to 10% as Trump to announce pharma tariffs 'soon'

Trump tariffs: Blue Jet Healthcare, Aarti Pharmalabs, Marksans Pharma, Ipca, Wockhardt, Ami Organics, Biocon, Piramal Pharma, Lupin, Laurus Labs and Gland Pharma dropped in the range of 3% to 10%

5 pharma stocks that you should stay away from given their tech charts

Technical charts hint that pharma shares such as Cipla, Lupin, Sun Pharma, Zydus Lifesciences and Gland Pharma could slide up to 23% as Trump tariff threat on pharma import looms.

Here's why Concord Biotech shares gained 5% in trade on April 9; details

The uptick in Concord Biotech share price came after the company was granted final approval from the USFDA for marketing its Teriflunomide Tablets, 7 mg and 14 mg

Here's why Dr. Reddy's share slipped 8%, hit 52-week low on Monday, April 7

The fall in Dr. Reddy's share price came after the company announced that it received approximately Rs 2,395-crore show cause notice from I-T department

Here's why Medicamen Biotech shares skyrocketed 12% in trade on April 3

Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.

Pharma stocks that you can keep in your portfolio despite US tariff woes

Tausif Shaikh, India analyst for pharma and healthcare, BNP Paribas India, prefers domestic-focused companies like Torrent Pharmaceuticals, and JB Chemicals and Pharmaceuticals in the sector

Stocks to Watch on Apr 3, 2025: IT, auto, pharma, Central Bank, Muthoot Fin

Stocks to Watch on Apr 3, 2025: As the US imposed ;reciprocal tariffs' IT, Pharma and auto related stocks will be in focus

Closing Bell: Benchmarks rebound; Trump tariff hit auto stocks, PSBs outrun

Auto stocks, on the other hand, witnessed a sell-off after US President Donald Trump announced a 25 per cent tariff on imported cars and key auto parts, effective April 3

Here's why Marksans Pharma share was buzzing in trade on March 20

The products will be manufactured at the Verna, Goa facility, and will be marketed & distributed in Australian markets through the Marksans Pharma's subsidiary Nova Pharmaceuticals Australasia Pty

Marksans Pharma up 3% as arm secures marketing authorisation for Baclofen

The northward move in Marksans Pharma came after the company's wholly-owned subsidiary, Relonchem, received Marketing Authorisation for the product Baclofen 10 mg Tablets from UK MHRA

Here's why Zydus Lifesciences share price popped 3% in trade on March 19

The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug Administration (USFDA) to manufacture Apalutamide Tablets, 60 mg

Here's why Zydus Lifesciences share price was buzzing in trade on March 17

The uptick in the Zydus Life shares came after the company received final approval from the USFDA to manufacture Eluxadoline Tablets, 75 mg and 100 mg